Open account
Sign up/Log in
MARKET
PROC
PROC
Procaps Group Sa
NASDAQ
2.970
+0.195
+7.03%
Closed 16:00 05/02 EDT
OPEN
2.700
PREV CLOSE
2.775
HIGH
3.240
LOW
2.700
VOLUME
3.29K
TURNOVER
0
52 WEEK HIGH
5.00
52 WEEK LOW
1.950
MARKET CAP
335.09M
P/E (TTM)
5.70
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PROC last week (0422-0426)?
Weekly Report · 4d ago
Weekly Report: what happened at PROC last week (0415-0419)?
Weekly Report · 04/22 12:22
Weekly Report: what happened at PROC last week (0408-0412)?
Weekly Report · 04/15 12:11
Weekly Report: what happened at PROC last week (0401-0405)?
Weekly Report · 04/08 12:18
Weekly Report: what happened at PROC last week (0325-0329)?
Weekly Report · 04/01 12:14
Weekly Report: what happened at PROC last week (0318-0322)?
Weekly Report · 03/25 12:18
Weekly Report: what happened at PROC last week (0311-0315)?
Weekly Report · 03/18 12:16
A Look Into Healthcare Sector Value Stocks
A value stock is traditionally defined in terms of how investors are valuing a company's future growth prospects. Low P/E multiples are good indicators that a company is undervalued. The following stocks are considered to be notable value stocks in the healthcare sector. A value stock may need some time to rebound from its undervalued position.
Benzinga · 03/11 14:43
About PROC
Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.
Webull offers Procaps Group SA stock information, including NASDAQ: PROC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PROC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading PROC stock methods without spending real money on the virtual paper trading platform.